Stock data
Oragenics Inc. (OGEN)
Oragenics Inc. (OGEN) reported net income of -US$9.84M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$9.36M | -US$9.84M | — |
| 2024 | — | — | -US$10.56M | -US$10.57M | — |
| 2023 | US$0.04M | — | -US$20.90M | -US$20.66M | — |
| 2022 | US$0.13M | — | -US$14.42M | -US$14.29M | — |
| 2021 | US$0.09M | — | -US$15.77M | -US$15.71M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$2.53M | — |
| 2026-03-31 | — | -US$2.20M | — |
| 2025-12-31 | — | -US$2.29M | — |
| 2025-09-30 | — | -US$3.07M | — |
| 2025-06-30 | — | -US$2.27M | — |
| 2025-03-31 | — | -US$2.22M | — |
| 2024-12-31 | — | -US$3.35M | — |
| 2024-09-30 | — | -US$2.46M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.